These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 9220020)

  • 1. Functional and structural analysis of R607Q and R608K androgen receptor substitutions associated with male breast cancer.
    Poujol N; Lobaccaro JM; Chiche L; Lumbroso S; Sultan C
    Mol Cell Endocrinol; 1997 Jun; 130(1-2):43-51. PubMed ID: 9220020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.
    Yong EL; Tut TG; Ghadessy FJ; Prins G; Ratnam SS
    Mol Cell Endocrinol; 1998 Feb; 137(1):41-50. PubMed ID: 9607727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A G577R mutation in the human AR P box results in selective decreases in DNA binding and in partial androgen insensitivity syndrome.
    Nguyen D; Steinberg SV; Rouault E; Chagnon S; Gottlieb B; Pinsky L; Trifiro M; Mader S
    Mol Endocrinol; 2001 Oct; 15(10):1790-802. PubMed ID: 11579211
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Molecular modeling and in vitro investigations of the human androgen receptor DNA-binding domain: application for the study of two mutations.
    Lobaccaro JM; Poujol N; Chiche L; Lumbroso S; Brown TR; Sultan C
    Mol Cell Endocrinol; 1996 Feb; 116(2):137-47. PubMed ID: 8647313
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.
    Thompson J; Saatcioglu F; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2001 Jun; 15(6):923-35. PubMed ID: 11376111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Androgen insensitivity syndrome due to new mutations in the DNA-binding domain of the androgen receptor.
    Imasaki K; Okabe T; Murakami H; Tanaka Y; Haji M; Takayanagi R; Nawata H
    Mol Cell Endocrinol; 1996 Jun; 120(1):15-24. PubMed ID: 8809734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Partial androgen insensitivity caused by an androgen receptor mutation at amino acid 907 (Gly-->Arg) that results in decreased ligand binding affinity and reduced androgen receptor messenger ribonucleic acid levels.
    Choong CS; Sturm MJ; Strophair JA; McCulloch RK; Tilley WD; Leedman PJ; Hurley DM
    J Clin Endocrinol Metab; 1996 Jan; 81(1):236-43. PubMed ID: 8550758
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel missense mutation in the amino-terminal domain of the human androgen receptor gene in a family with partial androgen insensitivity syndrome causes reduced efficiency of protein translation.
    Choong CS; Quigley CA; French FS; Wilson EM
    J Clin Invest; 1996 Sep; 98(6):1423-31. PubMed ID: 8823308
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel substitution (Leu707Arg) in exon 4 of the androgen receptor gene causes complete androgen resistance.
    Lumbroso S; Lobaccaro JM; Georget V; Leger J; Poujol N; Térouanne B; Evain-Brion D; Czernichow P; Sultan C
    J Clin Endocrinol Metab; 1996 May; 81(5):1984-8. PubMed ID: 8626869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impaired nuclear translocation, nuclear matrix targeting, and intranuclear mobility of mutant androgen receptors carrying amino acid substitutions in the deoxyribonucleic acid-binding domain derived from androgen insensitivity syndrome patients.
    Kawate H; Wu Y; Ohnaka K; Tao RH; Nakamura K; Okabe T; Yanase T; Nawata H; Takayanagi R
    J Clin Endocrinol Metab; 2005 Nov; 90(11):6162-9. PubMed ID: 16118342
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discordant measures of androgen-binding kinetics in two mutant androgen receptors causing mild or partial androgen insensitivity, respectively.
    Shkolny DL; Beitel LK; Ginsberg J; Pekeles G; Arbour L; Pinsky L; Trifiro MA
    J Clin Endocrinol Metab; 1999 Feb; 84(2):805-10. PubMed ID: 10022458
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An androgen receptor mutation in the direct vicinity of the proposed C-terminal alpha-helix of the ligand binding domain containing the AF-2 transcriptional activating function core is associated with complete androgen insensitivity.
    Peters I; Weidemann W; Romalo G; Knorr D; Schweikert HU; Spindler KD
    Mol Cell Endocrinol; 1999 Feb; 148(1-2):47-53. PubMed ID: 10221770
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Activation of two mutant androgen receptors from human prostatic carcinoma by adrenal androgens and metabolic derivatives of testosterone.
    Culig Z; Stober J; Gast A; Peterziel H; Hobisch A; Radmayr C; Hittmair A; Bartsch G; Cato AC; Klocker H
    Cancer Detect Prev; 1996; 20(1):68-75. PubMed ID: 8907206
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A point mutation in the second zinc finger of the DNA-binding domain of the androgen receptor gene causes complete androgen insensitivity in two siblings with receptor-positive androgen resistance.
    Mowszowicz I; Lee HJ; Chen HT; Mestayer C; Portois MC; Cabrol S; Mauvais-Jarvis P; Chang C
    Mol Endocrinol; 1993 Jul; 7(7):861-9. PubMed ID: 8413310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional interferences between normal or mutant androgen receptors and the activator protein 1--dissection of the androgen receptor functional domains.
    Lobaccaro JM; Poujol N; Térouanne B; Georget V; Fabre S; Lumbroso S; Sultan C
    Endocrinology; 1999 Jan; 140(1):350-7. PubMed ID: 9886845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and biochemical investigations and molecular analysis of subjects with mutations in the androgen receptor gene.
    Weidemann W; Linck B; Haupt H; Mentrup B; Romalo G; Stockklauser K; Brinkmann AO; Schweikert HU; Spindler KD
    Clin Endocrinol (Oxf); 1996 Dec; 45(6):733-9. PubMed ID: 9039340
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Partial androgen insensitivity with phenotypic variation caused by androgen receptor mutations that disrupt activation function 2 and the NH(2)- and carboxyl-terminal interaction.
    Quigley CA; Tan JA; He B; Zhou ZX; Mebarki F; Morel Y; Forest MG; Chatelain P; Ritzén EM; French FS; Wilson EM
    Mech Ageing Dev; 2004; 125(10-11):683-95. PubMed ID: 15541764
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Complete androgen insensitivity due to mutations in the probable alpha-helical segments of the DNA-binding domain in the human androgen receptor.
    Beitel LK; Prior L; Vasiliou DM; Gottlieb B; Kaufman M; Lumbroso R; Alvarado C; McGillivray B; Trifiro M; Pinsky L
    Hum Mol Genet; 1994 Jan; 3(1):21-7. PubMed ID: 8162033
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Oligospermic infertility associated with an androgen receptor mutation that disrupts interdomain and coactivator (TIF2) interactions.
    Ghadessy FJ; Lim J; Abdullah AA; Panet-Raymond V; Choo CK; Lumbroso R; Tut TG; Gottlieb B; Pinsky L; Trifiro MA; Yong EL
    J Clin Invest; 1999 Jun; 103(11):1517-25. PubMed ID: 10359561
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Complete androgen insensitivity syndrome caused by a novel mutation in the ligand-binding domain of the androgen receptor: functional characterization.
    Rosa S; Biason-Lauber A; Mongan NP; Navratil F; Schoenle EJ
    J Clin Endocrinol Metab; 2002 Sep; 87(9):4378-82. PubMed ID: 12213902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.